Literature DB >> 15235910

Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.

Susanna Petzmann1, Reinhard Ullmann, Iris Halbwedl, Helmut H Popper.   

Abstract

Carcinoid tumors are a heterogeneous group of neoplasms arising from the diffuse neuroendocrine system. Pulmonary as well as gastrointestinal carcinoids can be separated into those with low malignant and intermediate malignant potential. DNA losses of chromosome arm 11q are commonly seen in pulmonary neuroendocrine tumors. Conflicting results have been published comparing atypical with typical lung carcinoids with respect to imbalances of chromosome 11. In the present study, a DNA microarray with genomic clones mapped to chromosome 11 was created, and array comparative genomic hybridization (CGH) with DNA derived from formalin-fixed, paraffin-embedded tissue was performed. We investigated 4 typical and 12 atypical carcinoids of the lung and, for comparison, 9 gastrointestinal carcinoids and 6 endocrine pancreatic tumors. We have shown that formalin-fixed, paraffin-derived DNA can be successfully used for array CGH. Alterations of 11q were rarely detected not only in typical carcinoids of the lung but also in gastrointestinal carcinoids. Atypical lung carcinoids that comprised extensive DNA losses also presented retained fragments in between these deleted regions. The array CGH data were consistent with the data of a previously published classical CGH study and were additionally confirmed using fluorescence in situ hybridization in the present investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235910     DOI: 10.1007/s00428-004-1052-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

1.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.

Authors:  D Shalon; S J Smith; P O Brown
Journal:  Genome Res       Date:  1996-07       Impact factor: 9.043

2.  Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.

Authors:  S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

3.  Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.

Authors:  R Chakrabarti; E S Srivatsan; T F Wood; P J Eubanks; S A Ebrahimi; R A Gatti; E Passaro; M P Sawicki
Journal:  Genes Chromosomes Cancer       Date:  1998-06       Impact factor: 5.006

4.  High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization.

Authors:  Joris A Veltman; Eric F P M Schoenmakers; Bert H Eussen; Irene Janssen; Gerard Merkx; Brigitte van Cleef; Conny M van Ravenswaaij; Han G Brunner; Dominique Smeets; Ad Geurts van Kessel
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

5.  Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.

Authors:  K C O'Briant; G Bepler
Journal:  Genes Chromosomes Cancer       Date:  1997-02       Impact factor: 5.006

6.  Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Authors:  R Ullmann; A Schwendel; H Klemen; G Wolf; I Petersen; H H Popper
Journal:  Hum Pathol       Date:  1998-10       Impact factor: 3.466

7.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

8.  Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.

Authors:  S Lantuejoul; D Moro; R J Michalides; C Brambilla; E Brambilla
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394

9.  Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; M Ikenaga; P J Smith
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

10.  Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.

Authors:  Aristotle T Bamias; Maria C Bai; Niki J Agnantis; Michael C Michael; Yiannis P Alamanos; Stella V Stefanaki; Evagelia D Razi; Dimosthenis V Skarlos; Angelos M Kappas; Nicholas A Pavlidis
Journal:  Cancer Invest       Date:  2003-06       Impact factor: 2.176

View more
  4 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Authors:  Dorian R A Swarts; Sandra M H Claessen; Yvonne M H Jonkers; Robert-Jan van Suylen; Anne-Marie C Dingemans; Wouter W de Herder; Ronald R de Krijger; Egbert F Smit; Frederik B J M Thunnissen; Cornelis A Seldenrijk; Aryan Vink; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

3.  Protein phosphatase 2A Aα regulates Aβ protein expression and stability.

Authors:  Caitlin M O'Connor; Matthew T Hoffa; Sarah E Taylor; Rita A Avelar; Goutham Narla
Journal:  J Biol Chem       Date:  2019-02-22       Impact factor: 5.157

Review 4.  Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.

Authors:  Mark Kidd; Irvin M Modlin; Lisa Bodei; Ignat Drozdov
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.